Context Capital Management, LLC - BIOTECH ACQUISITION COMPANY ownership

BIOTECH ACQUISITION COMPANY's ticker is BIOTW and the CUSIP is G1125A116. A total of 1 filers reported holding BIOTECH ACQUISITION COMPANY in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Context Capital Management, LLC ownership history of BIOTECH ACQUISITION COMPANY
ValueSharesWeighting
Q4 2022$3
-99.9%
47,2000.0%0.00%
Q3 2022$3,000
-25.0%
47,2000.0%0.00%
Q2 2022$4,000
-82.6%
47,200
-51.4%
0.00%
-100.0%
Q1 2022$23,000
-64.1%
97,2000.0%0.00%
-80.0%
Q4 2021$64,00097,2000.01%
Other shareholders
BIOTECH ACQUISITION COMPANY shareholders Q1 2023
NameSharesValueWeighting ↓
RAMIUS ADVISORS LLC 501,826$432,0000.16%
Kingstown Capital 300,000$258,0000.15%
Telemetry Investments, L.L.C. 85,000$73,0000.10%
Corbin Capital Partners, L.P. 464,062$399,0000.08%
Atalaya Capital Management LP 278,437$239,0000.06%
Radcliffe Capital Management, L.P. 202,950$1,963,0000.06%
Kamunting Street Capital Management, L.P. 158,962$137,0000.06%
DG Capital Management, LLC 224,999$193,0000.04%
MMCAP International Inc. SPC 300,000$258,0000.01%
PERISCOPE CAPITAL INC. 248,300$213,0000.01%
View complete list of BIOTECH ACQUISITION COMPANY shareholders